Colin D. Mansfield

Statistics

Publications

Citations

1.8K

H-Index

Active since

1998

Affiliations

Centre National de la Recherche Scientifique(Current)

AB Science (France)

Inserm

Université Paris Cité

Hôpital Necker-Enfants Malades

Colin D. Mansfield is an author at Centre National de la Recherche Scientifique specializing in medicine, pharmacology, and tyrosine kinase inhibitor therapy.

ORCID

Publications per year

1998–2023

Publications

Masitinib (AB1010), a Potent and Selective Tyrosine Kinase Inhibitor Targeting KIT

Patrice Dubreuil, Sébastien Letard, Marco A. Ciufolini et al. · PLoS ONE · 2009 · 412 citations · Full text

Medicine, Oncology, Pharmacology +15

Masitinib as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomized clinical trial

Jesús S. Mora, Angela Genge, Adriano Chiò et al. · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · 2019 · 222 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Masitinib for treatment of severely symptomatic indolent systemic mastocytosis: a randomised, placebo-controlled, phase 3 study

Olivier Lortholary, Marie‐Olivia Chandesris, C. Bulaï Livideanu et al. · The Lancet · 2017 · 122 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +6

Masitinib for the treatment of systemic and cutaneous mastocytosis with handicap: A phase 2a study

C. Paul, B. Sans, Felipe Suárez et al. · American Journal of Hematology · 2010 · 114 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +14

Masitinib for mild-to-moderate Alzheimer’s disease: results from a randomized, placebo-controlled, phase 3, clinical trial

Bruno Dubois, Jesús López‐Arrieta, Stanley Lipschitz et al. · Alzheimer s Research & Therapy · 2023 · 94 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

1–5 of 27